254 related articles for article (PubMed ID: 33663521)
1. Combining losartan with radiotherapy increases tumor control and inhibits lung metastases from a HER2/neu-positive orthotopic breast cancer model.
Li W; Li S; Chen IX; Liu Y; Ramjiawan RR; Leung CH; Gerweck LE; Fukumura D; Loeffler JS; Jain RK; Duda DG; Huang P
Radiat Oncol; 2021 Mar; 16(1):48. PubMed ID: 33663521
[TBL] [Abstract][Full Text] [Related]
2. The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma.
Coulson R; Liew SH; Connelly AA; Yee NS; Deb S; Kumar B; Vargas AC; O'Toole SA; Parslow AC; Poh A; Putoczki T; Morrow RJ; Alorro M; Lazarus KA; Yeap EFW; Walton KL; Harrison CA; Hannan NJ; George AJ; Clyne CD; Ernst M; Allen AM; Chand AL
Oncotarget; 2017 Mar; 8(12):18640-18656. PubMed ID: 28416734
[TBL] [Abstract][Full Text] [Related]
3. Prime-boost vaccination with plasmid and adenovirus gene vaccines control HER2/neu+ metastatic breast cancer in mice.
Wang X; Wang JP; Rao XM; Price JE; Zhou HS; Lachman LB
Breast Cancer Res; 2005; 7(5):R580-8. PubMed ID: 16168101
[TBL] [Abstract][Full Text] [Related]
4. Real-time Tumor Oxygenation Changes After Single High-dose Radiation Therapy in Orthotopic and Subcutaneous Lung Cancer in Mice: Clinical Implication for Stereotactic Ablative Radiation Therapy Schedule Optimization.
Song C; Hong BJ; Bok S; Lee CJ; Kim YE; Jeon SR; Wu HG; Lee YS; Cheon GJ; Paeng JC; Carlson DJ; Kim HJ; Ahn GO
Int J Radiat Oncol Biol Phys; 2016 Jul; 95(3):1022-1031. PubMed ID: 27130790
[TBL] [Abstract][Full Text] [Related]
5. DNA vaccination against neu reduces breast cancer incidence and metastasis in mice.
Lachman LB; Rao XM; Kremer RH; Ozpolat B; Kiriakova G; Price JE
Cancer Gene Ther; 2001 Apr; 8(4):259-68. PubMed ID: 11393278
[TBL] [Abstract][Full Text] [Related]
6. [Chimeric T cell receptor N29gamma redirect T lymphocytes response specific to p185HER2 in A murine model of metastatic breast cancer].
Li SP; Urban FA; Macgregor JN; Hughes DP; McDonagh KT
Ai Zheng; 2004 Nov; 23(11 Suppl):1370-5. PubMed ID: 15566639
[TBL] [Abstract][Full Text] [Related]
7. Enhanced therapeutic effect of multiple injections of HSV-TK + GCV gene therapy in combination with ionizing radiation in a mouse mammary tumor model.
Vlachaki MT; Chhikara M; Aguilar L; Zhu X; Chiu KJ; Woo S; Teh BS; Thompson TC; Butler EB; Aguilar-Cordova E
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1008-17. PubMed ID: 11704325
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II type 1 receptor blocker telmisartan inhibits the development of transient hypoxia and improves tumour response to radiation.
Wadsworth BJ; Cederberg RA; Lee CM; Firmino NS; Franks SE; Pan J; Colpo N; Lin KS; Benard F; Bennewith KL
Cancer Lett; 2020 Nov; 493():31-40. PubMed ID: 32763272
[TBL] [Abstract][Full Text] [Related]
9. Attenuated transforming growth factor beta signaling promotes metastasis in a model of HER2 mammary carcinogenesis.
Novitskiy SV; Forrester E; Pickup MW; Gorska AE; Chytil A; Aakre M; Polosukhina D; Owens P; Yusupova DR; Zhao Z; Ye F; Shyr Y; Moses HL
Breast Cancer Res; 2014 Oct; 16(5):425. PubMed ID: 25280532
[TBL] [Abstract][Full Text] [Related]
10. CCL4 as an adjuvant for DNA vaccination in a Her2/neu mouse tumor model.
Nguyen-Hoai T; Pham-Duc M; Gries M; Dörken B; Pezzutto A; Westermann J
Cancer Gene Ther; 2016 Jun; 23(6):162-7. PubMed ID: 27056671
[TBL] [Abstract][Full Text] [Related]
11. Caloric restriction coupled with radiation decreases metastatic burden in triple negative breast cancer.
Simone BA; Dan T; Palagani A; Jin L; Han SY; Wright C; Savage JE; Gitman R; Lim MK; Palazzo J; Mehta MP; Simone NL
Cell Cycle; 2016 Sep; 15(17):2265-74. PubMed ID: 27027731
[TBL] [Abstract][Full Text] [Related]
12. Flavopiridol increases therapeutic ratio of radiotherapy by preferentially enhancing tumor radioresponse.
Mason KA; Hunter NR; Raju U; Ariga H; Husain A; Valdecanas D; Neal R; Ang KK; Milas L
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1181-9. PubMed ID: 15234054
[TBL] [Abstract][Full Text] [Related]
13. T cells sensitized with breast tumor progenitor cell vaccine have therapeutic activity against spontaneous HER2/neu tumors.
Wang LX; Plautz GE
Breast Cancer Res Treat; 2012 Jul; 134(1):61-70. PubMed ID: 22173696
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2
Nagpal A; Redvers RP; Ling X; Ayton S; Fuentes M; Tavancheh E; Diala I; Lalani A; Loi S; David S; Anderson RL; Smith Y; Merino D; Denoyer D; Pouliot N
Breast Cancer Res; 2019 Aug; 21(1):94. PubMed ID: 31409375
[TBL] [Abstract][Full Text] [Related]
15. Regulating cancer associated fibroblasts with losartan-loaded injectable peptide hydrogel to potentiate chemotherapy in inhibiting growth and lung metastasis of triple negative breast cancer.
Hu C; Liu X; Ran W; Meng J; Zhai Y; Zhang P; Yin Q; Yu H; Zhang Z; Li Y
Biomaterials; 2017 Nov; 144():60-72. PubMed ID: 28823844
[TBL] [Abstract][Full Text] [Related]
16. Treatment of implanted mammary tumors with recombinant vesicular stomatitis virus targeted to Her2/neu.
Bergman I; Griffin JA; Gao Y; Whitaker-Dowling P
Int J Cancer; 2007 Jul; 121(2):425-30. PubMed ID: 17354238
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the Kit ligand/c-Kit axis attenuates metastasis in a mouse model mimicking local breast cancer relapse after radiotherapy.
Kuonen F; Laurent J; Secondini C; Lorusso G; Stehle JC; Rausch T; Faes-Van't Hull E; Bieler G; Alghisi GC; Schwendener R; Andrejevic-Blant S; Mirimanoff RO; Rüegg C
Clin Cancer Res; 2012 Aug; 18(16):4365-74. PubMed ID: 22711708
[TBL] [Abstract][Full Text] [Related]
18. Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response.
Kodumudi KN; Ramamoorthi G; Snyder C; Basu A; Jia Y; Awshah S; Beyer AP; Wiener D; Lam L; Zhang H; Greene MI; Costa RLB; Czerniecki BJ
Front Immunol; 2019; 10():1939. PubMed ID: 31475002
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral heterogeneity impacts the response to anti-neu antibody therapy.
Song H; Kim TO; Ma SY; Park JH; Choi JH; Kim JH; Kang MS; Bae SK; Kim KH; Kim TH; Seo SK; Choi IW; Song GA; Mortenson ED; Fu YX; Park S
BMC Cancer; 2014 Sep; 14():647. PubMed ID: 25179116
[TBL] [Abstract][Full Text] [Related]
20. Metastatic breast cancer with HER2/neu-positive cells tends to have a morbid prognosis.
Emi Y; Kitamura K; Shikada Y; Kakeji Y; Takahashi I; Tsutsui S
Surgery; 2002 Jan; 131(1 Suppl):S217-21. PubMed ID: 11821814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]